Mds With Excess Blasts (mds Eb) - Histology

Relevant Publications

Gut Microbiota Composition Correlates with Disease Severity in Myelodysplastic Syndrome.

Issue Release: 2024

Multiple autoimmune disorders refractory to glucocorticoids after allogeneic hematopoietic stem cell transplantation: a case report and review of the literature.

Issue Release: 2024

Decitabine-containing conditioning improved outcomes for children with higher-risk myelodysplastic syndrome undergoing allogeneic hematopoietic stem cell transplantation.

Issue Release: 2024

Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms.

Issue Release: 2024

A case of peripheral T-cell lymphoma in which therapy-related myelodysplastic syndrome developed and a second autologous transplantation was performed.

Issue Release: 2024

A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists.

Issue Release: 2024

Spontaneous remission and loss of monosomy 7: a window of opportunity for young children with SAMD9L syndrome.

Issue Release: 2023

Targeted NGS on sequential bone marrow biopsies aids in the evaluation of cytopenias and monocytosis and documents clonal evolution-a proof of principle study.

Issue Release: 2023

Tuberculosis-induced aplastic crisis and atypical lymphocyte expansion in advanced myelodysplastic syndrome: A case report and review of literature.

Issue Release: 2023

Identification of a Complex Karyotype Signature with Clinical Implications in AML and MDS-EB Using Gene Expression Profiling.

Issue Release: 2023

Molecular characterization and prognosis of mutant TP53 acute myeloid leukemia and myelodysplastic syndrome with excess blasts.

Issue Release: 2023

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.

Issue Release: 2023

Single-center, observational study of AML/MDS-EB with IDH1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.

Issue Release: 2023

Implications of the 5 Edition of the World Health Organization Classification and International Consensus Classification of Myeloid Neoplasm in Myelodysplastic Syndrome With Excess Blasts and Acute Myeloid Leukemia.

Issue Release: 2023

Myelodysplastic Syndrome with Excess Blasts 2 (MDS-EB-2): A Historical Overview and Review of Forthcoming Classifications.

Issue Release: 2023

Poor pretransplantation minimal residual disease clearance as an independent prognostic risk factor for survival in myelodysplastic syndrome with excess blasts: A multicenter, retrospective cohort study.

Issue Release: 2023

[Novel germline SAMD9 mutation in an elderly patient with myelodysplastic syndrome].

Issue Release: 2022

t(10;12)(q24;q15): A new cytogenetic marker in hematological malignancies.

Issue Release: 2022

Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.

Issue Release: 2022

Bone marrow ring sideroblasts in hematological diseases: an analysis of consecutive 1300 samples in a single institution.

Issue Release: 2022

Why is Image Annotation Important?

How Does Histology Aid in the Diagnosis of Trophozoites?

What are In Vivo Models?

What Are the Key Steps in Histology-Based Drug Discovery?

What is Sucrose?

How Can Access Control Systems Help?

What are the Four Basic Tissue Types?

What Role Does Data Integrity Play in Histology?

What Role Does Vendor Reputation Play?

Why Do Embedding Issues Occur?

Mds With Excess Blasts (mds Eb) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics